Meeting Reports (Ethics)Journal of Pharmacology and PharmacotherapeuticsVol. 11 | Issue 4 | 2021 | pp. 145–147Open access
Scenarios in Medical Ethics 2: Challenges for Ethics Committees
- 1*,
- 1,
- 2,
- 3
- 1 Department of Pharmacology, JIPMER, Puducherry, India.
- 2 Department of Paediatrics and Critical Care, JIPMER, Puducherry, India.
- 3 Department of Pharmacology, Saveetha Medical College, Chennai, Tamil Nadu, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Jayanthi Mathaiyan
Department of Pharmacology, JIPMER, Puducherry, India.
Email: drjayanthi2008@gmail.com
Copyright: © 2021 Manuscript Technomedia LLP. This is an open access article.
- Published:
- May 14, 2021
- Received:
- Dec 24, 2020
- Accepted:
- Dec 29, 2020
How to cite
Mathaiyan, J., Natarajan, H., Parameswaran, N., & Suthakaran, C. (2021). Scenarios in Medical Ethics 2: Challenges for Ethics Committees. Journal of Pharmacology and Pharmacotherapeutics, 11(4), 145–147. https://doi.org/10.4103/jpp.jpp_172_20
Abstract
A series of panel discussions were conducted as part of the 2-day workshop on medical research ethics, organized for Ethics committee (EC) members at the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India, in association with Indian Council of Medical Research (ICMR) Bioethics Unit, Bangalore, India, in September, 2019. During the panel discussions, 3–6 scenarios were discussed followed by 1–3 questions. After presenting each scenario, the participants were invited to give their comments. After a thorough discussion, a set of panelists, who were experts in biomedical ethics, were invited to discuss the scenario and provide more informed and authoritative opinions. The discussions were quite lively and we believe that the case scenarios should be of wider interest. A summary of the first panel discussion on Scenarios in Medical Ethics 1: Composition and functioning of ethics committees were published previously in this journal. In this article, we discuss the second panel discussion on “Challenges for Ethics Committees.” The answers provided by the participants are listed first followed by the expert opinion by the panelists.
Keywords
Subject
Article metadata
| Title | Scenarios in Medical Ethics 2: Challenges for Ethics Committees |
|---|---|
| Authors | Jayanthi Mathaiyan; Harivenkatesh Natarajan; Narayanan Parameswaran; C. Suthakaran |
| Affiliations | Department of Pharmacology, JIPMER, Puducherry, India.; Department of Paediatrics and Critical Care, JIPMER, Puducherry, India.; Department of Pharmacology, Saveetha Medical College, Chennai, Tamil Nadu, India. |
| Corresponding author | drjayanthi2008@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 11, Issue 4 (2021) |
Also in this issue
- Adaptive Designs in Clinical Trialspp. 129–133
- Comparison of Topical Ivermectin and Oral Ivermectin in the Treatment of Human Scabies: A Randomized Controlled Trialpp. 134–139
- Late-Onset Clozapine-Induced Agranulocytosis in a Young Woman with Paranoid Schizophreniapp. 140–141
- Scenarios in Medical Ethics-1: Composition and Functioning of Ethics Committeespp. 142–144
- Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019pp. 148–150
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026